DNA Methylation and Genetic Aberrations in Gastric Cancer
暂无分享,去创建一个
A. Kaneda | M. Fukayama | T. Ushiku | K. Matsusaka | Genki Usui | Yasunobu Mano | Masayuki Urabe | Sayaka Funata | Atsushi Kaneda
[1] T. Kanda,et al. Cross-species chromatin interactions drive transcriptional rewiring in Epstein–Barr virus–positive gastric adenocarcinoma , 2020, Nature Genetics.
[2] A. Kaneda,et al. Epstein‐Barr virus‐positive gastric cancer involves enhancer activation through activating transcription factor 3 , 2020, Cancer science.
[3] K. White,et al. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent CCNE1 and IGF2 enhancer hijacking in primary gastric adenocarcinoma , 2019, Gut.
[4] T. Ushijima,et al. Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues , 2018, Proceedings of the National Academy of Sciences.
[5] A. Iwama,et al. Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus , 2017, Scientific Reports.
[6] H. Aburatani,et al. Epstein–Barr virus infection induces genome‐wide de novo DNA methylation in non‐neoplastic gastric epithelial cells , 2017, The Journal of pathology.
[7] H. Aburatani,et al. Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection. , 2017, Oncotarget.
[8] T. Ushijima,et al. How to stomach an epigenetic insult: the gastric cancer epigenome , 2017, Nature Reviews Gastroenterology &Hepatology.
[9] N. Yamamichi,et al. High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study , 2016, Gut.
[10] Shawn M. Gillespie,et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas , 2015, Nature.
[11] Daniel S. Day,et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods , 2015, Science.
[12] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[13] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[14] N. Yamamichi,et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study , 2014, Gut.
[15] Shibing Deng,et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer , 2014, Nature Genetics.
[16] Atsushi Tanaka,et al. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma , 2014, Nature Genetics.
[17] A. Kaneda,et al. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. , 2014, World journal of gastroenterology.
[18] H. Grabsch,et al. Gastric Cancer Pathology and Underlying Molecular Mechanisms , 2013, Digestive Surgery.
[19] T. Tsukamoto,et al. Prevention of Helicobacter pylori–Induced Gastric Cancers in Gerbils by a DNA Demethylating Agent , 2013, Cancer Prevention Research.
[20] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[21] H. Aburatani,et al. Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. , 2012, Cancer research.
[22] M. S. Lee,et al. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction , 2012, Oncogene.
[23] H. Aburatani,et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. , 2011, Cancer research.
[24] A. Iwashita,et al. Gastric Adenocarcinoma of Fundic Gland Type (Chief Cell Predominant Type): Proposal for a New Entity of Gastric Adenocarcinoma , 2010, The American journal of surgical pathology.
[25] Takeshi Toyoda,et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. , 2010, Cancer research.
[26] B. Christensen,et al. Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context , 2009, PLoS genetics.
[27] A. Kaneda,et al. High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk , 2006, Clinical Cancer Research.
[28] A. Feinberg,et al. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. , 2005, Cancer research.
[29] A. Feinberg,et al. Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice , 2005, Science.
[30] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[31] A. Kaneda,et al. Identification of silencing of nine genes in human gastric cancers. , 2002, Cancer research.
[32] S. Baylin,et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. , 1999, Cancer research.
[33] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[34] S. Natsugoe,et al. Distribution of p 53 mutations in esophageal and gastric carcinomas and the relationship with p 53 expression , 2006 .
[35] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[36] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.